The co-project leader of Replica, Massimo Caruso, has been invited by the Temple University (USA) to hold a lecture about the results achieved during the first year of the Replica project
CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania
Under the leadership of CoEHAR, a team of international researchers, examined the 24 most frequently cited vaping studies published in medical journals. The findings are shocking: almost all of these studies were found to be methodologically flawed; they lacked a clear hypothesis, used inadequate methodology, failed to collect data relevant to the study objectives, and did not correct for obvious confounding factors.
The annual meeting of SRNT, the Society for Research on Nicotine and Tobacco, kicks off on March 15. The conference will host a panel of international experts to discuss the latest news on policy, smoking endgame strategies, scientific research and innovation
Direct causal relationship between smoking and COVID-19 outcomes: the work of CoEHAR researchers finds confirmations in an english cohort study. Compared with people who had never smoked, current smoking was associated with one-third lower risk of hospitalization
43rd Annual Convention of the Philippine College of Occupational Medicine (PCOM), with which we are organizing a satellite symposium entitled “Tobacco Harm Reduction (THR)”. Title: “Potential Impact of THR on…
The House of Representatives and the Senate of the Philippines approved on third Reading the Vaporized Nicotine Product Bill to regulate the manufacture, sale and use of e-cigarettes and heated tobacco products
In the last two years, the CoEHAR Replica project confirmed the results obtained from the major international studies. It also validated with additional techniques their outcomes under independent conditions.
The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa
2022 SRNT Annual Meeting - Baltimora Poster Presentation Giovanni Li Volti and Massimo Caruso "E-CIGS EXHIBIT LOWER TOXICITY COMPARED TO CIGARETTES: THE REPLICA STUDY GROUP EXPERIENCE" "COMPARISON OF DIFFERENT CYTOTOXICITY…
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.